269 related articles for article (PubMed ID: 19118018)
1. Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells.
Ara T; Song L; Shimada H; Keshelava N; Russell HV; Metelitsa LS; Groshen SG; Seeger RC; DeClerck YA
Cancer Res; 2009 Jan; 69(1):329-37. PubMed ID: 19118018
[TBL] [Abstract][Full Text] [Related]
2. Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma.
Ara T; Nakata R; Sheard MA; Shimada H; Buettner R; Groshen SG; Ji L; Yu H; Jove R; Seeger RC; DeClerck YA
Cancer Res; 2013 Jul; 73(13):3852-64. PubMed ID: 23633489
[TBL] [Abstract][Full Text] [Related]
3. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
[TBL] [Abstract][Full Text] [Related]
4. Identification of galectin-3-binding protein as a factor secreted by tumor cells that stimulates interleukin-6 expression in the bone marrow stroma.
Fukaya Y; Shimada H; Wang LC; Zandi E; DeClerck YA
J Biol Chem; 2008 Jul; 283(27):18573-81. PubMed ID: 18450743
[TBL] [Abstract][Full Text] [Related]
5. Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells.
Chatterjee M; Stühmer T; Herrmann P; Bommert K; Dörken B; Bargou RC
Blood; 2004 Dec; 104(12):3712-21. PubMed ID: 15297310
[TBL] [Abstract][Full Text] [Related]
6. Soluble IL-6R alpha upregulated IL-6, MMP-1 and MMP-2 secretion in bone marrow stromal cells.
Barillé S; Collette M; Thabard W; Bleunven C; Bataille R; Amiot M
Cytokine; 2000 Sep; 12(9):1426-9. PubMed ID: 10976008
[TBL] [Abstract][Full Text] [Related]
7. Secretion of interleukin-6 by bone marrow mesenchymal stem cells promotes metastasis in hepatocellular carcinoma.
Mi F; Gong L
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28659496
[TBL] [Abstract][Full Text] [Related]
8. A galectin-3-dependent pathway upregulates interleukin-6 in the microenvironment of human neuroblastoma.
Silverman AM; Nakata R; Shimada H; Sposto R; DeClerck YA
Cancer Res; 2012 May; 72(9):2228-38. PubMed ID: 22389450
[TBL] [Abstract][Full Text] [Related]
9. Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells.
Borriello L; Nakata R; Sheard MA; Fernandez GE; Sposto R; Malvar J; Blavier L; Shimada H; Asgharzadeh S; Seeger RC; DeClerck YA
Cancer Res; 2017 Sep; 77(18):5142-5157. PubMed ID: 28687621
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I receptor expression regulates neuroblastoma metastasis to bone.
van Golen CM; Schwab TS; Kim B; Soules ME; Su Oh S; Fung K; van Golen KL; Feldman EL
Cancer Res; 2006 Jul; 66(13):6570-8. PubMed ID: 16818629
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6: a bone marrow stromal cell paracrine signal that induces neuroendocrine differentiation and modulates autophagy in bone metastatic PCa cells.
Delk NA; Farach-Carson MC
Autophagy; 2012 Apr; 8(4):650-63. PubMed ID: 22441019
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow mesenchymal stem cells provide an alternate pathway of osteoclast activation and bone destruction by cancer cells.
Sohara Y; Shimada H; Minkin C; Erdreich-Epstein A; Nolta JA; DeClerck YA
Cancer Res; 2005 Feb; 65(4):1129-35. PubMed ID: 15734993
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6/interleukin-6 receptor complex promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells.
Xie Z; Tang S; Ye G; Wang P; Li J; Liu W; Li M; Wang S; Wu X; Cen S; Zheng G; Ma M; Wu Y; Shen H
Stem Cell Res Ther; 2018 Jan; 9(1):13. PubMed ID: 29357923
[TBL] [Abstract][Full Text] [Related]
14. Expression of IL-6 receptor and GP130 in mouse bone marrow cells during osteoclast differentiation.
Gao Y; Morita I; Maruo N; Kubota T; Murota S; Aso T
Bone; 1998 May; 22(5):487-93. PubMed ID: 9600782
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2.
Valcárcel M; Mendoza L; Hernández JJ; Carrascal T; Salado C; Crende O; Vidal-Vanaclocha F
J Transl Med; 2011 Aug; 9():142. PubMed ID: 21867538
[TBL] [Abstract][Full Text] [Related]
16. Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells.
Zhang C; Soori M; Miles FL; Sikes RA; Carson DD; Chung LW; Farach-Carson MC
Prostate; 2011 Feb; 71(2):157-67. PubMed ID: 20665531
[TBL] [Abstract][Full Text] [Related]
17. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
[TBL] [Abstract][Full Text] [Related]
18. In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway.
Chatterjee M; Hönemann D; Lentzsch S; Bommert K; Sers C; Herrmann P; Mathas S; Dörken B; Bargou RC
Blood; 2002 Nov; 100(9):3311-8. PubMed ID: 12384432
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis.
Podgorski I; Linebaugh BE; Koblinski JE; Rudy DL; Herroon MK; Olive MB; Sloane BF
Am J Pathol; 2009 Sep; 175(3):1255-69. PubMed ID: 19700761
[TBL] [Abstract][Full Text] [Related]
20. The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation.
Peng H; Sohara Y; Moats RA; Nelson MD; Groshen SG; Ye W; Reynolds CP; DeClerck YA
Cancer Res; 2007 Oct; 67(19):9346-55. PubMed ID: 17909043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
